mySkin retweeted
🚨 Booking NOW OPEN 🚨
Our Annual Conference 2026 is here!
🎤 Challenges, Opportunities & Solutions
📍 Manchester
💡 Expert insights | World-class speakers | One unmissable day
🎟️ £15 Members | £25 Non-Members & HCPs
🔗 Book your place today! ow.ly/11gF50YoBJn
mySkin retweeted
Did you know that you can connect with other people living with psoriasis and psoriatic arthritis on our forums and closed Facebook Group?
Find our forums here ow.ly/BBVe50TPARC
mySkin retweeted
Today we’re supporting #RareDiseaseDay 💜
This year’s theme, Equity for Rare, calls for fair and equitable care for everyone — no matter how rare their condition.
While psoriasis isn’t rare, some forms are, including GPP and Erythrodermic Psoriasis.
We’ve just launched our Erythrodermic Psoriasis Information Sheet to help raise awareness.
ow.ly/QOVQ50YkU0j
mySkin retweeted
Did you know that you can connect with other people living with psoriasis and psoriatic arthritis on our forums and closed Facebook Group?
Find our forums here ow.ly/BBVe50TPARC
mySkin retweeted
We are looking for adults with palmoplantar pustulosis, diagnosed by a dermatologist, to take part in the JAKPPPOT trial.
During the trial, participants will take a tablet once-a-day for 8 weeks. This tablet will be a janus kinase inhibitor, a new group of drugs that suppresses the immune system. The drug is called upadacitinib (its brand name is ‘Rinvoq’).
Participants will attend our clinic at Guy’s and St Thomas’s NHS Trust, London Bridge, regularly during the 8-week trial, and we will take blood samples at each visit. We will also invite participants to take part in a voluntary interview before and after the 8 weeks of treatment to understand their thoughts on the tablet and the trial more generally.
We have reached 75% of our recruitment target so far, and are very keen to fill the last few spaces as soon as possible! Up to £50 travel expenses can be reimbursed per study visit.
Participants will need to be over the age of 18, and cannot be pregnant or breast-feeding. Participants will need to stop all UV light related treatment or systemic treatment (medications taken by mouth or injected) that they are currently taking, but they can continue using certain topical treatments (creams/ointments).
Please contact Dr David Gleeson at [email protected] to find out more.
#pustularpsoriasis #psoriasisresearch #skinhealth #dermatologyresearch
mySkin retweeted
📢Register for our free webinar with St John's Derm📢
Join us for ‘Weight Matters in Psoriasis: Understanding the link between body weight and psoriasis’ chaired by Dr Satveer Mahil and featuring talks from Professor Michael Simpson and Abhihit Gulati.
Prof. Michael is the Professor of Genetics and Head of one Development of Medical Molecular Genetics at King’s College London and Abhiti is the Lead Integrated Pharmacist for Diabetes and Obesity for South East London.
💻Register your place here us06web.zoom.us/webinar/regi…
mySkin retweeted
Take a look at what we have planned for this years Psoriasis Awareness Week!
Starting from Wednesday 29th October, our activities include:
👋 An info day at ASDA in Small Heath, Birmingham.
👚 Put on Purple Day. Wear our favourite colour to show your support.
☕ A virtual Coffee Morning.
🤳 An Instagram Live Q&A with a Rheumatologist.
💻 A free webinar with the experts from St John's DermAcademy.
We'll also be sharing your stories and more resources and info on Comorbidities of psoriasis throughout the week, so make sure you get involved!
Find out more details on our website ow.ly/1vGj50X0Wka
mySkin retweeted
🔬We would be really grateful for your feedback on a new research project led by dermatologists at St John's Institute of Dermatology, King's College London on improving access to effective psoriasis care for hard-to-reach/under-served populations using digital self-assessment in the community.
💻Please drop in to our virtual feedback session on Teams any time between 5pm and 6pm next Thursday 16th October to meet the research team, hear more about the study and how to get involved, and provide your feedback on the study.
As a small token of our appreciation for your time and feedback, you will receive £20 (eVoucher) after attending the session.
We are incredibly grateful for your time and thoughts so that we can ensure the study is impactful in ultimately improving health and wellbeing of everyone with psoriasis through enabling equitable and timely access to effective treatments.
If you are interested in attending the virtual feedback session next Thursday 16th October, please email the research team on [email protected].
mySkin retweeted
Hear from Psoriasis Association trustee, Adam Bushby, research associate and patient representative Dr Olivia Hughes and @myskinstudy participant Katie Farmer about their personal experience of taking part in #psoriasis research.
Watch the full panel discussion on our YouTube channel youtu.be/qOz95daT484
mySkin retweeted
The @myskinstudy have found that stress was the most common trigger for psoriasis onset and worsening.
Dr Manpreet Sagoo and the team tell us more about what they have learnt about psoriasis triggers from people sharing their lived experiences in the study.
📽️You can now watch the full video on our YouTube channel here youtu.be/RX5_6yEzywU
mySkin retweeted
Dr Manpreet Sagoo is giving us all a run down on the latest from @myskinstudy
#RightTreatmentRightTime
mySkin retweeted
Are you an adult living with Palmoplantar Pustulosis?
Doctors and researchers from Guy's and St Thomas' NHS Trust want to know whether a new group of drugs, JAK inhibitors, can be used to treat palmoplantar pustulosis.
Find out more here ow.ly/tX2B50W0FsS

ALT New Research Opportunity Are you an adult with Palmoplantar Pustulosis? Doctors and researchers from Guy's and St Thomas' NHS Trust want to know whether a new group of drugs, JAK inhibitors, can be used to treat palmoplantar pustulosis. To find out more, head to the link in our bio and click on 'Take Part in Research.' You can also contact the team directly on [email protected] for more info.
mySkin retweeted
Help researchers address problems relevant to people with psoriasis, by completing this short survey here from Dr Manpreet Sagoo: ow.ly/mC9950VUMTi
You can find out more information about the study here ow.ly/lw1950VUMTj
mySkin retweeted
Professor Catherine Smith will be speaking at our Annual Meeting this year, telling us all about the future of psoriasis research.
This talk will also cover updates from the mySkinstudy.
Grab your spot and join us on 28th June ow.ly/f89H50VJHSF
mySkin retweeted
BIOMAP’s Public Patient Webinar – Exciting Insights and lively Q&A! A public patient webinar took place last week, with around 60 participants from across Europe gathering to learn about #BIOMAP_IMI’s latest results. Slides and recording available NOW👉biomap-imi.eu/patients/webin…
mySkin retweeted
📢BOOKING IS NOW LIVE for our 'Right Treatment: Right Time' Annual Meeting in June📢
Join us at County Hall in London for a great day of talks from leading psoriasis clinicians and researchers.
Book your place here ow.ly/Fjji50VluJE
mySkin retweeted
📢 Do you have #eczema or #psoriasis? You are invited to a FREE online meeting to explore the complexities of eczema and psoriasis with leading experts.
🗓️ 25 March 2025, 17:30–19:00 CET / 16:30–18:00 GMT
📍 Online via Zoom
✍️ Register now via this link: sanofi.zoom.us/webinar/regis…
mySkin retweeted
Are you an adult with palmoplantar pustulosis?
To find out more, head to our website where you can find more details ow.ly/K8wm50UrCxa
You can also contact the team directly on [email protected]
mySkin retweeted
What will psoriasis care in the future look like?
Watch the video from our webinar with @StJ_DermAcademy where Dr Manpreet Sagoo talks us through exciting new research in the psoriasis world!
Watch it here ow.ly/T8Xv50UeJov
mySkin retweeted
Get involved in mySkin this Psoriasis Awareness Week!
Created by the doctors and scientists of St John’s Institute of Dermatology, the mySkin survey is designed to find out how and why psoriasis changes over time.
ow.ly/nFIj50TUcGK
#PAW24 #PsoCommunity
























